Pyridoxine-dependent epilepsy

Alpha-aminoadipic semialdehyde (alpha-AASA) dehydrogenase deficiency was shown to cause pyridoxine-dependent epilepsy in a considerable number of patients. alpha-AASA dehydrogenase deficiency is an autosomal recessive disorder characterized by a neonatal-onset epileptic encephalopathy in which seizures are resistant to antiepileptic drugs but respond immediately to the administration of pyridoxine. Increased plasma and urinary levels of alpha-AASA are associated with pathogenic mutations in the alpha-AASA dehydrogenase (ALDH7A1/antiquitin) gene.

In a study by Plecko et al. involving 18 patients with neonatal seizure onset, the c.1279G>C mutation in the ALDH7A1 gene, accounted for 12 of 36 alleles. This variant results in a p.Glu427Gln substitution. In vitro functional expression studies in hamster ovary cells showed that the mutant enzyme had no detectable activity.

Salomons et al. identified a homozygous 1279G>C mutation in 7 Dutch patients from 4 apparently unrelated families with pyridoxine-dependent epilepsy.

Genes analyzed

ALDH7A1

Haven't you taken a DNA test yet?

Get your genetic test and find out all about yourself.

starter

Ancestry, Traits and Wellness

advanced

Health, Ancestry, Traits and Wellness

CYBER MONDAY Deal

Until November 28

Up to -25% on our DNA tests

Code CYBER25